TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/27/24 17:09 | 11/26/24 | PYXS | Pyxis Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Connealy Pamela Ann | MA | O | CFO,COO | P | 174 | 1.96 | 0 | 89 | 4 | 2,315 | I | ||||||||||||||
9/28/23 16:32 | 9/28/23 | PYXS | Pyxis Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Connealy Pamela Ann | MA | O | CFO,COO | P | 15 | 1.87 | 0 | 8 | 1 | 819 | D | ||||||||||||||
9/27/23 18:36 | 9/27/23 | PYXS | Pyxis Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Connealy Pamela Ann | MA | O | CFO,COO | P | 12 | 1.85 | 0 | 6 | 1 | 811 | D | ||||||||||||||
9/25/23 17:04 | 9/25/23 | PYXS | Pyxis Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Connealy Pamela Ann | MA | O | CFO,COO | P | 20 | 1.67 | 0 | 12 | 2 | 804 | D | ||||||||||||||
9/22/23 19:34 | 9/22/23 | PYXS | Pyxis Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Connealy Pamela Ann | MA | O | CFO,COO | P | 9 | 1.74 | 0 | 5 | 1 | 792 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |